SEC Filings and Other Disclosures. Notwithstanding any provision of this Agreement to the contrary: (a) Either Party may disclose the terms of this Agreement to the extent required, in the reasonable opinion of such Party’s legal counsel, to comply with Applicable Law, including the rules and regulations promulgated by the SEC or any equivalent governmental agency in any country in the Territory. Notwithstanding the foregoing, before disclosing this Agreement or any of the terms hereof pursuant to this Section 7.2.3, the Parties will consult with one another on the terms of this Agreement to be redacted in making any such disclosure. Further, if a Party discloses this Agreement or any of the terms hereof in accordance with this Section 7.2.3, such Party shall, at its own expense, seek such confidential treatment of confidential portions of this Agreement and such other terms, as may be reasonably requested by the other Party. (b) Either Party may disclose the existence and terms of this Agreement in confidence: (i) (A) to its attorneys, professional accountants, and auditors, and (B) bankers or other financial advisors in connection with an initial public offering, other strategic transaction, or corporate valuation for internal purposes; provided that any such disclosure to such professional accountants, auditors, bankers or other financial advisors is under an agreement to keep the terms of confidentiality and non-use no less rigorous than the terms contained in this Agreement and to use such information solely for the applicable purpose permitted pursuant to this Section 7.2.3(b)(i); (ii) to potential acquirers (and their respective attorneys and professional advisors), in connection with a potential merger, acquisition or reorganization; provided that (A) the Party making the disclosure has a bona fide offer from such Third Party for such a transaction, and (B) such disclosure is under an agreement to keep the terms of confidentiality and non-use no less rigorous than the terms contained in this Agreement and to use such information solely for the purpose permitted pursuant to this Section 7.2.3(b)(i); (iii) to existing or potential investors, lenders or permitted assignees of such Party (and their respective attorneys and professional advisors); provided that such disclosure is under an agreement to keep the terms of confidentiality and non-use no less rigorous than the terms contained in this Agreement; and (iv) to potential licensees or sublicensees of such Party (and their respective attorneys and professional advisors); provided that (A) such disclosure shall not include any financial terms or identify any Research Project Targets or Reserved Targets; and (B) such disclosure is under an agreement to keep the terms of confidentiality and non-use no less rigorous than the terms contained in this Agreement.
Appears in 3 contracts
Samples: Research Collaboration and License Agreement (Macrogenics Inc), Research Collaboration and License Agreement (Macrogenics Inc), Research Collaboration and License Agreement (Macrogenics Inc)
SEC Filings and Other Disclosures. Notwithstanding any provision of this Agreement to the contrary:
(a) Either Party may disclose the terms of this Agreement to the extent required, in the reasonable opinion of such Party’s legal counsel, to comply with Applicable applicable Law, including the rules and regulations promulgated by the SEC United States Securities and Exchange Commission (“SEC”) or any equivalent governmental agency in any country in the Territory. Notwithstanding the foregoing, before Before disclosing this Agreement or any of the terms hereof pursuant to this Section 7.2.37.3, the Parties will consult with one another on the terms of this Agreement to be redacted in making any such disclosuredisclosure (which, at a minimum, shall include redaction of all financial terms), with the disclosing Party providing as much advanced notice as is feasible under the circumstances, and giving consideration to the comments of the other Party. Further, if a Party discloses this Agreement or any of the terms hereof in accordance with this Section 7.2.37.3, such Party shall, at its own expense, seek such confidential treatment of confidential portions of this Agreement and such other terms, as may be reasonably requested by the other Party. CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[…***…]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT UNDER RULE 24B-2 PROMULGATED UNDER THE SECURITIES ACT OF 1934, AS AMENDED.
(b) Either Party may disclose the existence and terms of this Agreement in confidence:
(i) (A) to its attorneys, professional accountants, and auditors, and (B) bankers or other financial advisors in connection with an initial public offering, other strategic transaction, or corporate valuation for internal purposes; provided that any such disclosure to such professional accountants, auditors, bankers or other financial advisors is under an agreement to keep the terms of confidentiality and non-use no less rigorous than the terms contained in this Agreement and to use such information solely for the applicable purpose permitted pursuant to this Section 7.2.3(b)(i);
(ii) to potential acquirers (and their respective attorneys and professional advisors), in connection with a potential merger, acquisition or reorganization; provided that (A) the Party making the disclosure has a bona fide offer from such Third Party for such a transaction, and (B) such disclosure is under an agreement to keep the terms of confidentiality and non-use no less rigorous than the terms contained in this Agreement and to use such information solely for the purpose permitted pursuant to this Section 7.2.3(b)(i);
(iii) to existing or potential investors, lenders or permitted assignees of such Party (and their respective attorneys and professional advisors); provided that such disclosure is under an agreement to keep the terms of confidentiality and non-use no less rigorous than the terms contained in this Agreement; and
(iv) to potential licensees or sublicensees of such Party (and their respective attorneys and professional advisors); provided that (A) such disclosure shall not include any financial terms or identify any Research Project Targets or Reserved Targets; and (B) such disclosure is under an agreement to keep the terms of confidentiality and non-use no less rigorous than the terms contained in this Agreement.
Appears in 2 contracts
Samples: License Agreement (Palatin Technologies Inc), License Agreement (Amag Pharmaceuticals Inc.)
SEC Filings and Other Disclosures. Notwithstanding any provision of this Agreement to the contrary:
(a) Either Party may disclose the terms of this Agreement and make any other public written disclosure regarding the existence of, or performance under, this Agreement, to the extent required, in the reasonable opinion of such Party’s legal counsel, to comply with Applicable (a) applicable Law, including the rules and regulations [*] = Certain confidential information contained in this document, marked by brackets, has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. promulgated by the SEC United States Securities and Exchange Commission or (b) any equivalent governmental agency Governmental Authority, securities exchange or securities regulator in any country in the Territory. Notwithstanding the foregoing, before Before disclosing this Agreement or any of the terms hereof pursuant to this Section 7.2.311.4, the Parties will shall consult with one another on with respect to the terms timing, form, and content of such disclosure. If so requested by the other Party, the Party subject to such obligation shall use reasonable efforts to obtain an order protecting, to the maximum extent possible and not prohibited by applicable Law (as reasonably determined by the disclosing Party in consultation with its legal counsel), the confidentiality of such provisions of this Agreement to be redacted in making any such disclosure. Further, if a Party discloses this Agreement or any of the terms hereof in accordance with this Section 7.2.3, such Party shall, at its own expense, seek such confidential treatment of confidential portions of this Agreement and such other terms, as may be reasonably requested by the other Party.
(b) Either . Notwithstanding the foregoing, if the Parties are unable to agree on the form or content of any required disclosure, such disclosure shall be limited to the minimum required as reasonably determined by the disclosing Party may disclose in consultation with its legal counsel. Without limiting the existence foregoing, each Party shall provide the other Party with each proposed filing by such Party with the United States Securities and Exchange Commission or any equivalent Governmental Authority, securities exchange or securities regulator in any country in the Territory which describes the terms of this Agreement (including any filings of this Agreement) reasonably in confidence:
(i) (A) to its attorneys, professional accountantsadvance of submission of such filing, and auditors, and (B) bankers or other financial advisors shall reasonably consider in connection with an initial public offering, other strategic transaction, or corporate valuation for internal purposes; provided that any such disclosure good faith the reasonable comments of the reviewing Party relating to such professional accountantsfiling, auditors, bankers or other financial advisors is under an agreement to keep including the terms provisions of confidentiality and non-use no less rigorous than the terms contained in this Agreement and to use such information solely for the applicable purpose permitted pursuant to this Section 7.2.3(b)(i);
(ii) to potential acquirers (and their respective attorneys and professional advisors), in connection with a potential merger, acquisition or reorganization; provided that (A) the Party making the disclosure has a bona fide offer from such Third Party for such a transaction, and (B) such disclosure is under an agreement to keep the terms of confidentiality and non-use no less rigorous than the terms contained in this Agreement and to use such information solely for the purpose permitted pursuant to this Section 7.2.3(b)(i);
(iii) to existing or potential investors, lenders or permitted assignees of such Party (and their respective attorneys and professional advisors); provided that such disclosure is under an agreement to keep the terms of confidentiality and non-use no less rigorous than the terms contained in this Agreement; and
(iv) to potential licensees or sublicensees of such Party (and their respective attorneys and professional advisors); provided that (A) such disclosure shall not include any financial terms or identify any Research Project Targets or Reserved Targets; and (B) such disclosure is under an agreement to keep the terms of confidentiality and non-use no less rigorous than the terms contained in this Agreementwhich confidential treatment should be sought.
Appears in 1 contract
Samples: Collaboration and License Agreement (Sangamo Therapeutics, Inc)
SEC Filings and Other Disclosures. Notwithstanding any provision of this Agreement to the contrary:
(a) Either Party may disclose the terms of this Agreement only (a) to the extent required, in the reasonable opinion of such Party’s 's outside legal counsel, to comply with Applicable Law, including the rules and regulations promulgated by the SEC United States Securities and Exchange Commission or similar security regulatory authorities in other countries, or the rules and regulations of any equivalent governmental agency national exchange on which it is listed, (b) in any country connection with a 35 prospective acquisition, merger, financing or license for such Party, to prospective acquirers or merger candidates or to existing or potential investors or licensees, (c) in the Territory. Notwithstanding case of ALZA, to its directors, officers, employees, consultants and advisors and those of its Affiliates who, in such ALZA's sole discretion, have a need to know such information in order for ALZA to carry out the foregoingactivities and transactions contemplated by this Agreement, before disclosing this Agreement or any (d) in the case of the terms hereof Incline, to its shareholders holding information rights, provided that prior to such disclosure each such prospective acquirer, candidate, investor, licensee or shareholder receiving disclosure pursuant to this Section 7.2.3, the Parties will consult with one another on the terms of this Agreement clause (b) or (d) shall agree in writing to be redacted bound by obligations of confidentiality and non-use at least equivalent in making any such disclosurescope to those set forth in this Article 7. Further, if If a Party discloses must disclose this Agreement or any of the terms hereof in accordance with this Section 7.2.37.4(a), such Party shallagrees, at its own expense, to seek such confidential treatment of confidential portions of this Agreement and or such other terms, as may be reasonably requested by the other Party.
. Notwithstanding the foregoing, ALZA shall have the right to review and comment (bprovided such comments are received within five (5) Either Party may disclose business days) on the existence and terms contents of this Agreement in confidence:
any Incline registration statement or other offering document (i) (Ae.g., a prospectus) to the extent it contains the name of or any information about ALZA or any of its attorneys, professional accountants, and auditors, and (B) bankers or other financial advisors Affiliates in connection with an initial public offering, other strategic transaction, or corporate valuation for internal purposes; provided that any such disclosure to such professional accountants, auditors, bankers or other financial advisors is under an agreement to keep the terms of confidentiality and non-use no less rigorous than the terms contained in this Agreement and to use such information solely for the applicable purpose permitted pursuant to this Section 7.2.3(b)(i);
(ii) to potential acquirers (and their respective attorneys and professional advisors), in connection with a potential merger, acquisition or reorganization; provided that (A) the Party making the disclosure has a bona fide offer from such Third Party for such a transaction, and (B) such disclosure is under an agreement to keep the terms of confidentiality and non-use no less rigorous than the terms contained in this Agreement and to use such information solely for the purpose permitted pursuant to this Section 7.2.3(b)(i);
(iii) to existing or potential investors, lenders or permitted assignees of such Party (and their respective attorneys and professional advisors); provided that such disclosure is under an agreement to keep the terms of confidentiality and non-use no less rigorous than the terms contained in this Agreement; and
(iv) to potential licensees or sublicensees of such Party (it being understood and their respective attorneys and professional advisors); provided that (A) agreed that, except in the case such disclosure may, upon advice of counsel acceptable to both Incline and ALZA, be required by applicable law, ALZA's reasonable approval shall not include be required for any financial terms disclosure referring to it or identify any Research Project Targets or Reserved Targets; and (B) such disclosure is under an agreement to keep the terms of confidentiality and non-use no less rigorous than the terms contained in this Agreementits Affiliates.
Appears in 1 contract
Samples: License and Asset Transfer Agreement (Medicines Co /De)